Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

J Natl Cancer Inst. 2003 Jul 2;95(13):1010-1; author reply 1012-3. doi: 10.1093/jnci/95.13.1010.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Breast Neoplasms / chemically induced*
  • Breast Neoplasms / genetics
  • Contraceptives, Oral, Hormonal / adverse effects*
  • Female
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Heterozygote
  • Humans
  • Mutation*
  • Risk Assessment
  • Risk Factors

Substances

  • Contraceptives, Oral, Hormonal